Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02066246
Other study ID # ANA-UKE-PV4374
Secondary ID
Status Completed
Phase N/A
First received January 22, 2014
Last updated October 8, 2014
Start date August 2013
Est. completion date September 2014

Study information

Verified date October 2014
Source Universitätsklinikum Hamburg-Eppendorf
Contact n/a
Is FDA regulated No
Health authority Germany: Ethics Commission
Study type Interventional

Clinical Trial Summary

The aim of our study is to investigate if the use of the AirSeal insufflation system impairs the lung function of patients less than a conventional system in patients undergoing robot-assisted laparoscopic radical prostatectomy (RALP). Therefore we examine the lung function before and after surgery.

As a second purpose of the study, in a subgroup, we investigate the influence of the gas insufflators (AirSeal and conventional) on hemodynamics during surgery. Furthermore we study the change in the lung perfusion-ventilation-ratio by using the electric impedance tomography technique.


Recruitment information / eligibility

Status Completed
Enrollment 192
Est. completion date September 2014
Est. primary completion date September 2014
Accepts healthy volunteers No
Gender Male
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Patients scheduled for RALP

- Written informed consent

- = 18 years of age

Exclusion Criteria:

- Age under 18 years

- Patients who refuse participating in the study

- Obstructive airway disease (COPD and Asthma)

- Postoperative admission to an intensive or intermediate care unit

- Patients who do not speak German or English

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Supportive Care


Related Conditions & MeSH terms


Intervention

Device:
AirSeal
100 patients are treated with the AirSeal insufflation and trocar system
Olympus UHI-3
100 patients are treated with a conventional insufflation and trocar system

Locations

Country Name City State
Germany Prostate Cancer Center Northwest, at St. Antonius Hospital Gronau Gronau
Germany Department of Anaesthesiology Center of Anaesthesiology and Intensive Care Medicine University Medical Center Hamburg-Eppendorf University of Hamburg Hamburg

Sponsors (2)

Lead Sponsor Collaborator
Universitätsklinikum Hamburg-Eppendorf Prostate Center North West Department of Urology and Pediatric Urology

Country where clinical trial is conducted

Germany, 

Outcome

Type Measure Description Time frame Safety issue
Primary forced vital capacity (FVC) before operation, 1, 24, 120 hours after surgery No
Primary forced expiratory volume in one second (FEV1) before operation, 1, 24, 120 hours after surgery No
Secondary ventilation parameters peak pressure, positive end-expiratory pressure, end-tidal CO2, respiratory rate are recorded during surgery after induction, 30minutes after trendelenburg position, one hour after trendelenburg, two hours after trendelenburg (if operation has not been finished yet), patient in supine position No
Secondary hemodynamic parameters global end diastolic volume (GEDV), stoke volume variation (SVV); cardiac index (CI), extravascular lung water index (EVLWI) after induction, 30minutes after trendelenburg position, one hour after trendelenburg, two hours after trendelenburg (if operation has not been finished yet), patient in supine position No
Secondary electric impedance tomography after induction, 30minutes after trendelenburg position, one hour after trendelenburg, two hours after trendelenburg (if operation has not been finished yet), patient in supine position No
See also
  Status Clinical Trial Phase
Completed NCT04508270 - Significance of Early Mobilization After VATS-L
Recruiting NCT06063798 - Respiratory Effects of Flow-Controlled Ventilation and Jet Ventilation in Patients Undergoing Laryngotracheal Surgery N/A
Recruiting NCT03197701 - Maximal Effort-dependent Respiratory Flow Rates N/A
Completed NCT03659864 - The Role of Eicosanoids in the Cardiovascular Actions of Inhaled Nanoparticles N/A
Completed NCT01048021 - Pulmonary Function Changes and Diaphragmatic Paralysis Following Ultrasound Guided Supraclavicular Brachial Plexus Blockade: The Effects of Decreased Local Anesthetic Volume N/A
Active, not recruiting NCT05668624 - Sustainable Household Energy Adoption in Rwanda (SHEAR) N/A
Completed NCT03500614 - The Use of Air Cleaners to Mitigate Cardiopulmonary Health Impact of Indoor Exposure to Particles and Phthalates N/A
Recruiting NCT04611243 - Lung Function, Exercise Capacity, and Serology Responses in Patients With COVID-19
Recruiting NCT01609712 - Osteoporotic Vertebral Compression Fractures: Can Kyphoplasty Improve Lung Function? A Prospective Evaluation N/A
Completed NCT01593657 - Mindful Movement and Breathing to Improve Outcomes of Gynecologic Surgery N/A
Not yet recruiting NCT04747535 - Continuous Positive Airway Pressure After Abdominal Surgery N/A
Recruiting NCT06065215 - Early-life MRI Biomarkers of Longer-term Respiratory Morbidity in Infants Born Extremely Preterm (EMBLEM)
Completed NCT04767477 - Telerehabilitation and Face-to-face Rehabilitation on COVID-19 Survivors N/A
Completed NCT01004146 - Pre-op Use of Incentive Spirometry in Obese Patients N/A
Completed NCT06389734 - Combining Manual Soft Tissue Release and Exercise Training in COPD: the Effect on LF, EC, and CAF N/A
Completed NCT04316234 - Acute Health Effects of Passive Vape Among COPD Patients N/A
Completed NCT03237221 - Clinical Characteristics, Treatment and Prognosis of Chest Tightness Variant Asthma
Completed NCT02245178 - Lung Function Decline and Disease Risk From Young Adulthood to Middle Age
Completed NCT00706277 - Effect of Total Intravenous Anesthesia and Balanced Anesthesia on Postoperative Lung Function Phase 4
Recruiting NCT04322422 - Clinical Characteristics and Treatment of Chest Tightness Variant Asthma N/A